Peripheral Leukocyte Apoptosis in Patients with Parkinsonism: Correlation with Clinical Characteristics and Neuroimaging Findings
Table 2
Correlation analysis between leukocyte apoptosis, 99mTc-TRODAT-1 striatal uptake binding ratio, and clinical variables in the PD group after controlling for age and sex.
Variables
value
Total leukocyte apoptosis (%)
Striatal dopamine transporter uptake ratios mean
−0.349
0.020
Striatal dopamine transporter uptake ratios
−0.384
0.012
Striatal dopamine transporter uptake ratios
−0.252
0.108
UPDRS I
0.293
0.041
UPDRS II
0.480
0.000
UPDRS III
0.555
0.000
UPDRS total
0.537
0.000
Modified Hoehn-Yahr Staging Scale
0.461
0.001
Schwab and England Activities of Daily Living Scale
−0.463
0.001
Duration of disease
0.293
0.039
Neutrophil apoptosis (%)
Striatal dopamine transporter uptake ratios mean
−0.253
0.098
Striatal dopamine transporter uptake ratios
−0.272
0.082
Striatal dopamine transporter uptake ratios
−0.244
0.120
UPDRS I
0.120
0.413
UPDRS II
0.298
0.037
UPDRS III
0.356
0.012
UPDRS total
0.335
0.019
Modified Hoehn-Yahr Staging Scale
0.378
0.007
Schwab and England Activities of Daily Living Scale
−0.318
0.026
Duration of disease
0.145
0.315
Striatal dopamine transporter uptake ratios
UPDRS III
−0.349
0.019
UPDRS total
−0.330
0.027
Modified Hoehn-Yahr Staging Scale
−0.373
0.012
Striatal dopamine transporter uptake ratios
UPDRS II
−0.295
0.049
UPDRS III
−0.328
0.028
UPDRS total
−0.307
0.040
Modified Hoehn-Yahr Staging Scale
−0.390
0.008
Schwab and England Activities of Daily Living Scale
